Literature DB >> 10602149

Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation.

A H Briggs1, C Z Mooney, D E Wonderling.   

Abstract

The statistic of interest in most health economic evaluations is the incremental cost-effectiveness ratio. Since the variance of a ratio estimator is intractable, the health economics literature has suggested a number of alternative approaches to estimating confidence intervals for the cost-effectiveness ratio. In this paper, Monte Carlo simulation techniques are employed to address the question of which of the proposed methods is most appropriate. By repeatedly sampling from a known distribution and applying the different methods of confidence interval estimation, it is possible to calculate the coverage properties of each method to see if these correspond to the chosen confidence level. As the results of a single Monte Carlo experiment would be valid only for that particular set of circumstances, a series of experiments was conducted in order to examine the performance of the different methods under a variety of conditions relating to the sample size, the coefficient of variation of the numerator and denominator of the ratio, and the covariance between costs and effects in the underlying data. Response surface analysis was used to analyse the results and substantial differences between the different methods of confidence interval estimation were identified. The methods, both parametric and non-parametric, which assume a normal sampling distribution performed poorly, as did the approach based on simply combining the separate intervals on costs and effects. The choice of method for confidence interval estimation can lead to large differences in the estimated confidence limits for cost-effectiveness ratios. The importance of such differences is an empirical question and will depend to a large extent on the role of hypothesis testing in economic appraisal. However, where it is suspected that the sampling distribution is skewed, normal approximation methods produce particularly poor results and should be avoided. Copyright 1999 John Wiley & Sons, Ltd.

Mesh:

Year:  1999        PMID: 10602149     DOI: 10.1002/(sici)1097-0258(19991215)18:23<3245::aid-sim314>3.0.co;2-2

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  32 in total

1.  Handling uncertainty in economic evaluations of healthcare interventions.

Authors:  A H Briggs; A M Gray
Journal:  BMJ       Date:  1999-09-04

Review 2.  Sample size determination for cost-effectiveness trials.

Authors:  Andrew R Willan
Journal:  Pharmacoeconomics       Date:  2011-11       Impact factor: 4.981

3.  The value of value of information: best informing research design and prioritization using current methods.

Authors:  Simon Eckermann; Jon Karnon; Andrew R Willan
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

4.  Value of information and pricing new healthcare interventions.

Authors:  Andrew R Willan; Simon Eckermann
Journal:  Pharmacoeconomics       Date:  2012-06-01       Impact factor: 4.981

5.  Presenting evidence and summary measures to best inform societal decisions when comparing multiple strategies.

Authors:  Simon Eckermann; Andrew R Willan
Journal:  Pharmacoeconomics       Date:  2011-07       Impact factor: 4.981

6.  A system for evaluating inpatient care cost-efficiency in hospital.

Authors:  J Li; J Hawkins
Journal:  Proc AMIA Symp       Date:  2001

7.  Paying Low-Income Smokers to Quit? The Cost-Effectiveness of Incentivizing Tobacco Quit Line Engagement for Medicaid Recipients Who Smoke.

Authors:  Marlon P Mundt; Timothy B Baker; David L Fraser; Stevens S Smith; Megan E Piper; Michael C Fiore
Journal:  Value Health       Date:  2018-09-20       Impact factor: 5.725

8.  Economic evaluation of three two-drug chemotherapy regimens in advanced non-small-cell lung cancer.

Authors:  Niels Neymark; Pilar Lianes; Egbert F Smit; Jan P van Meerbeeck
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

9.  Nonparametric inference for time-dependent incremental cost-effectiveness ratios.

Authors:  Laura M Yee; Kwun Chuen Gary Chan
Journal:  Stat Med       Date:  2015-07-27       Impact factor: 2.373

10.  Cost-effectiveness of various diagnostic approaches for occupational asthma.

Authors:  Wendy A Kennedy; Frédéric Girard; Simone Chaboillez; André Cartier; Johanne Côté; Frederick Hargreave; Manon Labrecque; Jean-Luc Malo; Susan M Tarlo; Carrie A Redlich; Catherine Lemière
Journal:  Can Respir J       Date:  2007 Jul-Aug       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.